BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4006010)

  • 1. Interactions of safrole and isosafrole and their metabolites with cytochromes P-450.
    Ioannides C; Delaforge M; Parke DV
    Chem Biol Interact; 1985 May; 53(3):303-11. PubMed ID: 4006010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-complex formation between cytochromes P-450 and P-448 and methylenedioxyphenyl compounds.
    Delaforge M; Ioannides C; Parke DV
    Xenobiotica; 1985 Apr; 15(4):333-42. PubMed ID: 4024668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective reactivation of steroid hydroxylases following dissociation of the isosafrole metabolite complex with rat hepatic cytochrome P-450.
    Murray M; Zaluzny L; Farrell GC
    Arch Biochem Biophys; 1986 Dec; 251(2):471-8. PubMed ID: 3800378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro formation of an inhibitory complex between an isosafrole metabolite and rat hepatic cytochrome P-450 PB-B.
    Murray M; Reidy GF
    Drug Metab Dispos; 1989; 17(4):449-54. PubMed ID: 2571488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of specific cytochrome P-450 isozymes by methylenedioxyphenyl compounds and antagonism by 3-methylcholanthrene.
    Yeowell HN; Linko P; Hodgson E; Goldstein JA
    Arch Biochem Biophys; 1985 Dec; 243(2):408-19. PubMed ID: 4083893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of the safrole-induced mixed-function oxidase activities by 9-hydroxyellipticine.
    Delaforge M; Ioannides C; Parke DV
    Chem Biol Interact; 1982 Dec; 42(3):279-89. PubMed ID: 7151231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectral and inhibitory interactions of methylenedioxyphenyl and related compounds with purified isozymes of cytochrome P-450.
    Marcus CB; Murray M; Wilkinson CF
    Xenobiotica; 1985 Apr; 15(4):351-62. PubMed ID: 4024670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further studies on the dissociation of the isosafrole metabolite-cytochrome P-450 complex.
    Dickins M; Elcombe CR; Moloney SJ; Netter KJ; Bridges JW
    Biochem Pharmacol; 1979; 28(2):231-8. PubMed ID: 426839
    [No Abstract]   [Full Text] [Related]  

  • 9. The side-chain epoxidation and hydroxylation of the hepatocarcinogens safrole and estragole and some related compounds by rat and mouse liver microsomes.
    Swanson AB; Miller EC; Miller JA
    Biochim Biophys Acta; 1981 Apr; 673(4):504-16. PubMed ID: 7225430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand binding of safrole to cytochrome P-450.
    Delaforge M; Ioannides C; Parke DV
    Arch Toxicol Suppl; 1980; 4():45-8. PubMed ID: 6933961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the substrate-binding sites of liver microsomal cytochrome P-448.
    Phillipson CE; Ioannides C; Delaforge M; Parke DV
    Biochem J; 1982 Oct; 207(1):51-6. PubMed ID: 7181861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation, purification, and properties of a unique form of cytochrome P-450 in microsomes of isosafrole-treated rats.
    Fisher GJ; Fukushima H; Gaylor JL
    J Biol Chem; 1981 May; 256(9):4388-94. PubMed ID: 6783662
    [No Abstract]   [Full Text] [Related]  

  • 13. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole.
    Miller EC; Swanson AB; Phillips DH; Fletcher TL; Liem A; Miller JA
    Cancer Res; 1983 Mar; 43(3):1124-34. PubMed ID: 6825084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The induction of hepatic cytochrome P-450 in C57 BL/10 and DBA/2 mice by isosafrole and piperonyl butoxide. A comparative study with other inducing agents.
    Fennell TR; Sweatman BC; Bridges JW
    Chem Biol Interact; 1980 Aug; 31(2):189-201. PubMed ID: 7389009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cytochrome P-450 by methylenedioxyphenyl compounds: importance of the methylene carbon.
    Cook JC; Hodgson E
    Toxicol Appl Pharmacol; 1983 Mar; 68(1):131-9. PubMed ID: 6845372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate-elicited dissociation of a complex of cytochrome P-450 with a methylenedioxyphenyl metabolite.
    Elcombe CR; Bridges JW; Nimmo-Smith RH
    Biochem Biophys Res Commun; 1976 Aug; 71(4):915-9. PubMed ID: 971317
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of rat hepatic microsomal cytochrome P-450 by 2,3',4,4',5,5'-hexachlorobiphenyl.
    Parkinson A; Robertson LW; Safe SH
    Biochem Pharmacol; 1983 Jul; 32(14):2269-79. PubMed ID: 6409119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Properties of the safrole metabolite-cytochrome P-450 complex.
    Elcombe CR; Bridges JW; Netter KJ
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R72. PubMed ID: 1143487
    [No Abstract]   [Full Text] [Related]  

  • 19. The induction of cytochrome P-450 by isosafrole and related methylenedioxyphenyl compounds.
    Cook JC; Hodgson E
    Chem Biol Interact; 1985; 54(3):299-315. PubMed ID: 2996791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between the metabolism and toxicity of benzodioxole compounds.
    Bridges JW; Fennell TR
    Adv Exp Med Biol; 1981; 136 Pt B():881-93. PubMed ID: 7344519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.